Personalis Inc PSNL:NASDAQ

Last Price$10.19NASDAQ Previous Close - Last Trade as of 3:57PM ET 1/26/22

Today's Change-0.16(1.55%)
Bid (Size)N/A (N/A)
Ask (Size)N/A (N/A)
Day Low / High$10.08 - 11.43
Volume613.5 K

View Biotechnology IndustryPeer Comparison as of 01/26/2022


Personalis Inc ( NASDAQ )

Price: $10.19
Change: -0.16 (1.55%)
Volume: 613.5 K
3:57PM ET 1/26/2022

bluebird bio Inc ( NASDAQ )

Price: $7.72
Change: -0.04 (0.52%)
Volume: 1.7 M
3:57PM ET 1/26/2022

MiMedx Group Inc ( NASDAQ )

Price: $4.52
Change: -0.19 (4.03%)
Volume: 600.6 K
3:57PM ET 1/26/2022

Precigen Inc ( NASDAQ )

Price: $2.71
Change: -0.19 (6.55%)
Volume: 2.2 M
3:57PM ET 1/26/2022

Vaxart Inc ( NASDAQ )

Price: $4.53
Change: -0.17 (3.62%)
Volume: 20.00
3:57PM ET 1/26/2022

Read more news Recent News

Insider Sell: Personalis
6:16AM ET 1/20/2022 MT Newswires

John Stephen West, Director, President and CEO, on January 18, 2022, sold 99,987 shares in Personalis (PSNL) for $1,126,405. Following the Form 4 filing...

Personalis Shares Climb Higher in Afternoon Trading Following Preliminary Revenue Report
1:03PM ET 1/07/2022 MT Newswires

Personalis (PSNL) shares are up more than 8% in early Friday afternoon trading after the cancer genomics company reported preliminary Q4 and full-year 2021...

Personalis Expects $20.7 Million in Revenue for Q4'21
4:13PM ET 1/06/2022 MT Newswires

Personalis (PSNL) reported preliminary results Thursday and anticipates fourth-quarter revenue to be roughly $20.7 million. Revenue for the year ending...

-- Earnings Flash (PSNL) PERSONALIS Expects Q4 Revenue $20.7M
4:02PM ET 1/06/2022 MT Newswires


Company Profile

Business DescriptionPersonalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA. View company web site for more details
Address1330 O'Brien Drive
Menlo Park, California 94025
Number of Employees139
President, Chief Executive Officer & DirectorJohn S. West
Chief Financial OfficerAaron Tachibana
Chief Scientific OfficerRichard O. Chen
Vice President-Immunology, Research & DevelopmentXavier Paliard

Company Highlights

Price Open$10.87
Previous Close$10.19
52 Week Range$9.04 - 48.01
Market Capitalization$456.3 M
Shares Outstanding44.8 M
SectorHealth Technology
Next Earnings Announcement02/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.37
Beta vs. S&P 500N/A
Revenue$37.8 M
Net Profit Margin-68.68%
Return on Equity-19.34%

Analyst Ratings as of 01/07/2022

Consensus RecommendationConsensus Icon
Powered by Factset